Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Cipla Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	500087
ISIN Demat	INE059A01026
Book Value	378.53

NSE Code	CIPLA
Dividend Yield %	0.86
Market Cap	1218688.98

P/E	26.18
EPS	57.63
Face Value	2


	BSE		NSE

07-May-2025

Last Price	1508.95
Net Change	-1.75
% Change	-0.12%
Prev.Close	1510.70
Open	1510.50
High	1517.80
Low	1499.50
Volume	10503

Last Price	1508.80
Net Change	-2.6
% Change	-0.17%
Prev.Close	1511.40
Open	1500.00
High	1517.80
Low	1499.40
Volume	1424662

Value	15826314
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1517.80
52-Week High	1702.00
52-Week Low	1310.05

Value	2148507563.1
Best Buy	0.00
Best Sell	0.00
Best Quantity	0
Sell Quantity	0
Today's Range	1517.80
52-Week High	1702.05
52-Week Low	1317.25

Open Price	1505.00
High Price	1524.00
Low Price	1503.20
Last Price	1515.60
Prev Close	1515.80
Change	-0.20
% Change	-0.01 %

Average Price	1514.05
Underlying Value	1508.80
Number of contracts traded	2454
Turnover in Rs. Lakhs	12075
Open Interest	12298000.00
Change in O I	21770.00
% Change in O I	0.18 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	0
Price	0.00

Quantity	0
Price	0.00

Best Bid

Best Offer

Quantity	325
Price	1515.6

Quantity	325
Price	1516.4

Holding Details

Latest Corporate Events

Bonus

3 : 2

24-Apr-06

Book Closure

11-Aug-21

25-Aug-21

Dividend

650 %

02-Aug-24

Company News

21-04-2025

Cipla’s arm’s Goa facilit...

11-04-2025

Cipla informs about discl...

11-04-2025

Cipla gets USFDA’s final ...

11-04-2025

Cipla jumps on getting US...

24-02-2025

Cipla rises on the bourse...

21-02-2025

USFDA concludes cGMP insp...

21-02-2025

Cipla gets USFDA’s final ...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.